TWST · Insider Trading

Twist Bioscience Corporation Common Stock

Every open-market purchase and sale reported by TWST officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
43
code S
Reporting Insiders
13
current holders
TWST — Recent Form 4 Transactions (latest 2026-10-13)
FiledInsiderRole TypeSharesValue
2026-10-13 Adam Laponis Chief Financial Officer Sell −2,462 −$384.82K
2026-10-07 Emily M. Leproust Chief Executive Officer Sell −4,548 −$919.37K
2026-10-05 Emily M. Leproust Chief Executive Officer Sell −46,391 −$8.77M
2026-10-05 Dennis Cho See Remarks Sell −9,514 −$1.80M
2026-10-05 Robert F. Werner Chief Accounting Officer Sell −1,482 −$279.93K
2026-10-05 Adam Laponis Chief Financial Officer Sell −8,057 −$1.52M
2026-10-05 Patrick John Finn President and COO Sell −25,714 −$4.86M
2026-10-05 Paula Green SVP of Human Resources Sell −10,088 −$1.91M
2026-09-25 Emily M. Leproust Chief Executive Officer Sell −5,203 −$922.91K
2026-09-23 Paula Green SVP of Human Resources Sell −294 −$48.65K
2026-09-23 Dennis Cho See Remarks Sell −348 −$57.59K
2026-09-23 Emily M. Leproust Chief Executive Officer Sell −1,687 −$279.18K
2026-09-21 Emily M. Leproust Chief Executive Officer MIXED −147,838 −$52.11M
2026-09-10 Paula Green SVP of Human Resources Sell −907 −$111.22K
2026-09-10 Dennis Cho See Remarks Sell −412 −$50.52K
2026-09-10 Robert F. Werner Chief Accounting Officer Sell −238 −$29.18K
2026-09-10 Emily M. Leproust Chief Executive Officer Sell −2,302 −$282.28K
2026-08-27 Emily M. Leproust Chief Executive Officer Sell −41,570 −$6.32M
2026-08-25 Adam Laponis Chief Financial Officer Sell −1,965 −$273.26K
2026-08-25 Paula Green SVP of Human Resources Sell −1,360 −$189.13K
2026-08-25 Patrick John Finn President and COO Sell −4,046 −$562.66K
2026-08-25 Dennis Cho See Remarks Sell −1,598 −$222.23K
2026-08-25 Robert F. Werner Chief Accounting Officer Sell −1,523 −$213.26K
2026-08-25 Emily M. Leproust Chief Executive Officer Sell −6,639 −$923.26K
2026-08-21 Dennis Cho See Remarks Sell −14,205 −$1.84M
2026-08-20 Patrick John Finn President and COO MIXED −55,000 −$7.63M
2026-08-14 Katryn Blake Director Sell −2,240 −$275.25K
2026-08-14 Emily M. Leproust Chief Executive Officer MIXED — −$1.96M
2026-08-12 Emily M. Leproust Chief Executive Officer MIXED — −$11.16M
2026-08-11 Robert Chess Director MIXED — −$1.82M
2026-08-07 Dennis Cho See Remarks Sell −14,205 −$1.56M
2026-08-07 Dennis Cho See Remarks Sell −14,205 −$1.56M
2026-08-05 Paula Green SVP of Human Resources Sell −1,133 −$96.67K
2026-08-05 Patrick John Finn President and COO Sell −2,888 −$246.41K
2026-08-05 Emily M. Leproust Chief Executive Officer Sell −5,101 −$435.22K
2026-08-05 Dennis Cho See Remarks Sell −1,070 −$91.29K
2026-08-05 Robert F. Werner Chief Accounting Officer Sell −167 −$14.25K
2026-07-27 Patrick John Finn President and COO Sell −2,238 −$210.13K
2026-07-13 Adam Laponis Chief Financial Officer Sell −2,399 −$226.31K
2026-06-26 Dennis Cho See Remarks Sell −14,205 −$1.27M
2026-06-26 Emily M. Leproust Chief Executive Officer Sell −18,880 −$1.79M
2026-06-24 Dennis Cho See Remarks Sell −346 −$30.21K
2026-06-24 Paula Green SVP of Human Resources Sell −291 −$25.41K
2026-06-24 Emily M. Leproust Chief Executive Officer Sell −1,688 −$147.40K
2026-06-17 Paula Green SVP of Human Resources MIXED — −$1.52M
2026-06-10 Paula Green SVP of Human Resources Sell −884 −$61.74K
2026-06-10 Dennis Cho See Remarks Sell −402 −$28.08K
2026-06-10 Emily M. Leproust Chief Executive Officer Sell −2,265 −$158.20K
2026-06-10 Robert F. Werner Chief Accounting Officer MIXED −1,859 −$94.05K
2026-06-02 Dennis Cho See Remarks Sell −14,205 −$990.80K
TWST — Current Insider Holders
InsiderRole Shares HeldValue
Emily M. Leproust Chief Executive Officer 596,549 $86.65M
Patrick John Finn President and COO 185,088 $26.88M
Paula Green SVP of Human Resources 106,632 $15.49M
Keith Crandell Director 103,618 $15.05M
Adam Laponis Chief Financial Officer 98,114 $14.25M
Robert Chess Director 82,029 $11.91M
Dennis Cho See Remarks 63,789 $9.27M
Robert F. Werner Chief Accounting Officer 42,917 $6.23M
Nelson Chan Director 33,251 $4.83M
Jan Johannessen Director 29,754 $4.32M
Robert P Ragusa Director 28,983 $4.21M
Melissa A. Starovasnik Director 22,222 $3.23M
Katryn Blake Director 17,208 $2.50M
TWST Insider Trading FAQ
Who are the insiders at TWST?
13 officers, directors and 10%+ beneficial owners currently report holdings in TWST via SEC Form 4.
Are TWST insiders buying or selling?
Across the 50 most recent Form 4 filings for TWST, 0 were open-market purchases (code P) and 43 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is TWST insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent TWST filing is dated 2026-10-13.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the TWST quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.